Pancreas Transplants in Diabetic Nephropathy

  • David E. R. Sutherland
  • John S. Najarian
Part of the Developments in Nephrology book series (DINE, volume 9)


Pancreas-transplantation application for the treatment of diabetes mellitus has increased dramatically [1]. More pancreas transplants were performed in the 2 years from January 1, 1982, to December 31, 1983, than during the preceding 16 years [2], following the first transplant performed by Kelly and Lillehei and associates in 1966 [3].


Diabetic Nephropathy Islet Transplantation Pancreas Transplant Graft Survival Rate Cadaver Donor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Sutherland DER, Kendall D. Clinical pancreas and islet transplant registry report. Transpl Proc 17: 307–311, 1985.Google Scholar
  2. 2.
    Sutherland DER. Pancreas and islet transplantation registry data. World J Surg 8: 270–275, 1984.PubMedCrossRefGoogle Scholar
  3. 3.
    Kelly WD, Lillehei RC, Merkel FK, Idezuki Y, Goetz FC. Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy. Surgery 61: 827–837, 1967.PubMedGoogle Scholar
  4. 4.
    Brownlee MC, Cahill GF. Diabetic control and vascular complications. In: Atherosclerotic Reviews, Vol. 4, Paoletti R, Gatto AM (eds). New York: Raven Press, 1979, pp. 29–70.Google Scholar
  5. 5.
    Ungar RH. Meticulous control of diabetes: benefits, risks and precautions. Diabetes 31: 479–483, 1982.Google Scholar
  6. 6.
    White N, Skor DA, Cryer PE, Levandoski PA, Bier DM, Santiago JV. Identification or Type I diabetic patients at increased risk for hypoglycemia during intensive therapy. N Engl J Med 308: 485–491, 1983.PubMedCrossRefGoogle Scholar
  7. 7.
    Gerrish EW. Final Newsletter, American College of Surgeons/National Institutes of Health Organ Transplant Registry, June 30, 1977.Google Scholar
  8. 8.
    Sutherland DER. International human pancreas and islet transplant registry. Transpl Proc 12 (No. 4, Suppl. 2): 229–236, 1980.Google Scholar
  9. 9.
    Sutherland DER, Goetz FC, Najarian JS. 100 pancreas transplants at a single institution. Ann Surg 200: 414–438, 1984.PubMedCrossRefGoogle Scholar
  10. 10.
    Lillehei RC, Ruiz JO, Acquino C, Goetz FC. Transplantation of the pancreas. Acta Endocrinol 83 (Suppl. 205): 303–320, 1976.Google Scholar
  11. 11.
    Sutherland DER, Goetz FC, Najarian JS. Recent experience with 89 pancreas transplants between 1978 and 1983. Diabetologia 27: 149–153, 1984.PubMedCrossRefGoogle Scholar
  12. 12.
    Dubernard JM, Traeger J, Bosi E, et al. Transplantation for the treatment of insulin-dependent diabetes: clinical experience with polymer-obstructed pancreatic grafts using Neoprene. World J Surg 8: 262–266, 1984.PubMedCrossRefGoogle Scholar
  13. 13.
    Groth CG, Tyden G, Lundgren G, et al. Segmental pancreas transplantation with enteric exocrine diversion. World J Surg 8: 257–261, 1984.PubMedCrossRefGoogle Scholar
  14. 14.
    Land W, Illner WD, Abendroth D, Landgraf R. Experience with segmental pancreas transplants in cyclosporine treated diabetic patients using Ethibloc for duct obliteration. Transpl Proc 16: 729–732, 1984.Google Scholar
  15. 15.
    Calne RY, White DJG. The use of cyclosporine in clinical organ grafting. Ann Surg 196:-330–337, 1982.PubMedCrossRefGoogle Scholar
  16. 16.
    Baumgartner D, Largiader F. Simultaneous renal and intraperitoneal segmental pancreatic transplantation: the Zurich experience. World J Surg 8: 267–269, 1984.PubMedCrossRefGoogle Scholar
  17. 17.
    Toledo-Pereyra LH. Pancreas transplantation. Surg Gynecol Obset 157: 49–56, 1983.Google Scholar
  18. 18.
    Sollinger HW, Cook K, Kamps D, Glass NR, Beizer FO. Clinical and experimental experience with pancreaticocystostomy for exocrine pancreatic drainage in pancreas transplantation. Tranpsl Proc 16: 749–751, 1984.Google Scholar
  19. 19.
    McMaster P, Michael J, Adu D, et al. Experience in human segmental pancreas transplantation. World J Surg 8: 253–256, 1984.PubMedCrossRefGoogle Scholar
  20. 20.
    Munda R, First MR, Webb CB, Alexander JW. Clinical experience with segmental pancreatic allografts. Transpl Proc 16: 692–694, 1984.Google Scholar
  21. 21.
    Sutherland DER, Goetz FC, Najarian JS. Pancreas transplantation. Clin Endocrin & Metabol 11: 549–578, 1982.CrossRefGoogle Scholar
  22. 22.
    Sutherland DER, Najarian JS, Greenberg BZ, Senske BJ, Anderson GE, Francis RS, Goetz FC. Hormonal and metabolic effects of an endocrine graft: vascularized segmental transplantation on the pancreas in insulin-dependent patients. Ann Int Med 95: 537–541, 1981.PubMedGoogle Scholar
  23. 23.
    Pozza G, Traeger J, DubernardJM, Serdri A, Pontiroli AE, Boss E, Malik MC, Ruitton A, Blanc N. Endocrine responses of type I (insulin-dependent) diabetic patients following successful pancreas transplantation. Diabetologia 24: 244–248, 1983.PubMedCrossRefGoogle Scholar
  24. 24.
    Sutherland DER, Kendall D. Pancreas transplant registry data. Transpl Today 2: 56–67, 1985.Google Scholar
  25. 25.
    Standards Committee of the American Society of Transplant Surgeons. Current results and expectations of renal transplantation. J Am Med Assoc 246: 1330–1331, 1981.CrossRefGoogle Scholar
  26. 26.
    Sutherland DER, Morrow CE, Fryd DS, Ferguson RM, Simmons RL, Najarian JS. Improved patient and primary renal allograft survival in uremic diabetic recipients. Transplantation 34:- 319–325, 1982.PubMedCrossRefGoogle Scholar
  27. 27.
    Lillehei RC, Simmons RL, Najarian JS, et al. Pancreatico-duodenal allotransplantation: experi-mental and clinical experience. Ann Surg 172: 405–436, 1970.PubMedCrossRefGoogle Scholar
  28. 28.
    Calne RY. Paratopic segmental pancreas grafting: a technique with portal venous drainage. Lancet 1: 595–597, 1984.PubMedCrossRefGoogle Scholar
  29. 29.
    Gliedman ML, Gold M, Whittaker J, Rifkin H, Soberman R, Freed S, Tellis V, Veith FJ. Clinical segmental pancreatic transplantation with ureter—pancreatic duct anastomosis for exocrine drainage. Surgery 74: 171–180, 1973.PubMedGoogle Scholar
  30. 30.
    Dubernard JM, Traeger J, Neyra P, Touraine JL, Tranchant D, Blanc-Brunat, N. A new method of preparation of segmental pancreatic grafts for transplantation: trials in dogs and in man. Surgery 84: 633–639, 1978.PubMedGoogle Scholar
  31. 31.
    Bjorken C, Lundgren G, Ringden O, Groth CG. A technique for rapid harvesting of cadaveric renal and pancreatic grafts after circulating arrest. Brit J Surg 63: 517–519, 1976.PubMedCrossRefGoogle Scholar
  32. 32.
    Sutherland DER, Goetz FC, Najarian JS. Living related donor segmental pancreatectomy for transplantation. Transpl Proc 12 (No. 4, Suppl. 2): 33–39, 1980.Google Scholar
  33. 33.
    Chinn P, Sutherland DER, Goetz FC, Elick BA, Najarian JS. Metabolic effects of hemipan- createctomy in living related graft donors. Transplant Proc 16: 11–17, 1984.Google Scholar
  34. 34.
    Sutherland DER, Goetz FC, Najarian JS. Pancreas transplants from related donors. Transplantation 38: 625–633, 1984.PubMedCrossRefGoogle Scholar
  35. 35.
    Starzl TE, Iwatsuki S, Shaw BW, et al. Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet 159: 265–272, 1984.PubMedGoogle Scholar
  36. 36.
    Sutherland DER, Chinn PL, Elick BA, et al. Maximization of islet mass in pancreas grafts by near total or total whole organ excision without duodenum from cadaver donors. Transplant Proc 16: 115–119, 1984.Google Scholar
  37. 37.
    Sollinger H, Hoffmann R, Beizer F. One year experience with pancreatico-cystostomy in human pancreas transplantation. Transpl Proc 17: 1985, in pressGoogle Scholar
  38. 38.
    Blanc-Brunat N, Dubernard JM, Touraine JL, et al. Pathology of the pancreas after intraductal neoprene injection in dogs and diabetic patients treated by pancreatic transplantation. Diabetologia 25: 97, 1983.PubMedCrossRefGoogle Scholar
  39. 39.
    Sutherland DER, Goetz FC, Najarian JS. Intraperitoneal transplantation of immediately vascularized segmental pancreatic grafts without duct litigation: a clinical trial. Transplantation 28:- 485–491, 1979.PubMedGoogle Scholar
  40. 40.
    Groth CG, Lundgren G, Arner P, Cellste H, Hardstedt C, Lewander R, Ostman J. Rejection of isolated pancreatic allografts in patients with diabetes. Surg Gynecol & Obstet 143: 933–940, 1976.Google Scholar
  41. 41.
    Sutherland DER, Ascher NL, Najarian JS. Pancreas transplantation. In: Manual of Organ Transplantation, Najarian JS, Simmons RL, (eds). New York: Springer-Verlag, 1984, pp. 237–254.Google Scholar
  42. 42.
    Sutherland DER, Goetz FC, Elick BA, Najarian JS. Experience with 49 segmental pancreas transplants in 45 diabetic patients. Transplantation 34: 330–338, 1982.PubMedCrossRefGoogle Scholar
  43. 43.
    Calne RY, White DJG, Rolles K, et al. Renal and segmental pancreatic grafting with drainage of exocrine secretions and initial continuous intravenous cyclosporin A in a patients with insulin-dependent diabetes and renal failure. Brit Med J 285: 677–680, 1982.CrossRefGoogle Scholar
  44. 44.
    Gil-Vernet JM, Fernandez-Cruz L, Corolps A, et al. Clinical experience with pancreatico-pyelostomy for exocrine pancreatic drainage and portal venous drainage in pancreas transplantation. Transpl Proc 17: 342–345, 1985.Google Scholar
  45. 45.
    Sutherland DER. Current status of clinical pancreas and islet transplantation with comments on need for and complications of cyrogenic and other preservation techniques. Cryobiology 20:- 245–255, 1983.PubMedCrossRefGoogle Scholar
  46. 46.
    Florack G, Sutherland DER, Chinn PL, et al. Clinical experience with transplantation of hypothermically preserved pancreas grafts. Transplant Proc 16: 153–155, 1984.Google Scholar
  47. 47.
    Najarian JS, Sutherland DER, Matas AJ, Steifes MW, Goetz FC. Human islet transplantation: a preliminary experience. Transpl Proc 9: 233–236, 1977.Google Scholar
  48. 48.
    Sutherland DER, Matas AJ, Najarian JS. Pancreatic islet cell transplantation. Surg Clinics of No Amer 58: 365–382, 1978.Google Scholar
  49. 49.
    Sutherland DER, Matas AJ, Goetz FC, Najarian JS. Transplantation of dispersed pancreatic islet tissue in humans: autografts and allografts. Diabetes 29 (Suppl l): 31–44, 1980.PubMedGoogle Scholar
  50. 50.
    Sutherland DER, Goetz FC, Carpenter AM, et al. Pancreatico-duodenal grafts: clinical and pathological observations in uremic versus nonuremic recipients. In: Transplantation and Clinical Immunology, Vol. X, Touraine JL, et al. (eds). Amsterdam: Excerpta Medica, 1979, pp. 90–195.Google Scholar
  51. 51.
    Sutherland DER, Goetz FC, Rynasiewicz JJ, Baumgartner D, White DC, Elick BA, Najarian JS. Segmental pancreas transplantation from living related and cadaver donors: a clinical experience. Surgery 90: 159–169, 1981.PubMedGoogle Scholar
  52. 52.
    Sutherland DER, Goetz FC, Kendall DM, Najarian JS. Effect of donor source, technique, immunosuppression and presence or absence of end stage diabetic nephropathy on outcome in pancreas transplant recipients. Transpl Proc 17: 325–330, 1985.Google Scholar
  53. 53.
    Sutherland DER, Chinn PL, Goetz FC, et al. Experience with cyclosporine vs. azathioprine for pancreas transplantation. Transplant Proc 15: 2606–2612, 1983.Google Scholar
  54. 54.
    Rynasiewicz JJ, Sutherland DER, Ferguson RM, et al. Cyclosporin A for immunosuppression: observations in rat heart, pancreas and islet allograft models and in human renal and pancreas transplantation. Diabetes 31 (Suppl. 4): 92–108, 1982.PubMedGoogle Scholar
  55. 54.
    Sibley RK, Mukai K. Pathological features in 29 segmental pancreas transplants in 27 diabetic patients. Lab Invest 48: 78A, 1983.Google Scholar
  56. 55.
    Sutherland DER, Sibley RK, Chinn PL, et al. Identical twin pancreas transplants: reversal and recurrence of pathogenesis in type I diabetes. Clin Res 32 (2): 561A, 1984.Google Scholar
  57. 56.
    Sibley RK, Sutherland DER, Goetz FC. Recurrence of type I diabetes mellitus in pancreatic allografts and isografts. Lab Invest 50: 54A, 1984.Google Scholar
  58. 57.
    Secchi A, Pontiroli AE, Traeger J, et al. A method of early detection of graft failure in pancreas transplantation. Transplantation 35: 344–348, 1983.PubMedCrossRefGoogle Scholar
  59. 58.
    Traeger J, Bosi E, Dubernard JM, et al. Thirty months experience with cyclosporine in human pancreatic transplantation. Diabetologia 27: 154–156, 1984.PubMedCrossRefGoogle Scholar
  60. 59.
    Sutherland DER, Bentley FR, Mauer SM, Menth L, Nylander W, Goetz FC, Barbosa J, Ascher NL, Simmons RL, Najarian JS. A report of 26 diabetic renal allograft recipients alive with functioning grafts at 10 or more years after primary transplantation. Diabetic Neprhopathy 3: 39–43, 1984.Google Scholar
  61. 60.
    Barker CF, Naji A, PerlofF LJ, Dafoe DC, Bartlett S. Invited commentary: an overview of pancreas transplantation—biologic aspects. Surgery 92: 113–137, 1982.Google Scholar
  62. 61.
    Faustman D, Hauptfeld V, Lacy P, Davie J. Prolongation of murine islet allograft survival by pretreatment of islets with antibody directed to la determinants. Proc Natl Acad Sci USA 78 (8): 5156–5159, 1981.PubMedCrossRefGoogle Scholar
  63. 62.
    Clark WH. (ed.) Proceedings of a workshop on preventing the rejection of transplanted pancreas or islets. Diabetes 31 (Suppl. 4):1–116, 1982.Google Scholar
  64. 63.
    Health Care Financing Administration (HCFA) Office of Special Programs. End-Stage Renal Disease Program Medical Information System, Facility Survey Tables, Department of Health and Human Services, USA, HCFA. January 1-December 31, 1981.Google Scholar
  65. 64.
    West KM. Epidemiology of diabetes and its vascular lesions. New York: Elsevier, 1978.Google Scholar
  66. 65.
    Bart KJ, Macon EJ, Whittier FC, Baldwin RJ, Blount JH. Cadaveric kidneys for transplantation. A paradox of shortage in the face of plenty. Transplantation 31: 379–387, 1981.PubMedCrossRefGoogle Scholar
  67. 66.
    Rosenbloom AL, Silverstein JH, Lezotte DC, Richardson K, McCallum RN. Limited joint mobility in childhood diabetes mellitus indicates increased risk for microvascular disease. N Eng J Med 305: 191–194, 1981.CrossRefGoogle Scholar
  68. 67.
    Merimee TJ, Zapf J, Froesch ER. Insulin-like growth factors. Studies in diabetes with and without retinopathy. N Engl J Med 309: 527–530, 1983.PubMedCrossRefGoogle Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston 1986

Authors and Affiliations

  • David E. R. Sutherland
  • John S. Najarian

There are no affiliations available

Personalised recommendations